What's Happening
2 hours ago
fool.com
The AI Memory Chip Market Could Reach $476 Billion by 2030. Here Are 2 Stocks Positioned to Win.
fool.com3 hours agofool.com
Sam Altman Is Waiting for a $1 Trillion OpenAI Valuation. SoftBank Has a $40 Billion Loan Due March 2027.
fool.com3 hours agofool.com
SpaceX Has Officially Joined the Nasdaq-100. Here Are 3 Better Nasdaq-100 Stocks to Buy in July.
fool.com3 hours agofool.com
What Is the State Street SPDR Portfolio Developed World ex-US ETF, and Who Should Buy It?
fool.com4 hours agofool.com
The Stock Market Just Flashed a Warning Sign Seen Only One Other Time Since 1890. History Couldn't Be Any Clearer About What Happens Next.
fool.com4 hours agofool.com
Palantir Could Hit a $400 Billion Market Cap by the End of 2027, and Here Is Why Investors Should Pay Attention
fool.com
marketbeat.com5 hours agofool.com
Better Buy for the Second Half: Celsius Down 36% or a 50/50 Split of Coca-Cola and Pepsi?
fool.com5 hours agofool.com
A Stock Market Correction Could Be Coming. Here's 1 Move All Investors Should Make Right Now.
fool.com6 hours agofool.com
If I Could Tell Every Investor 1 Thing About the Next 12 Months in the Stock Market, It's This
fool.com6 hours agofool.com
Google's In-House AI Chip Strategy Could Be a Bigger Threat to Nvidia Than Investors Think. Here's Why.
fool.com6 hours agofool.com
This Possible Social Security "Fix" Would Act as an Indirect Benefit Cut to Millions of Americans
fool.com6 hours ago
retire.ly
This Possible Social Security “Fix” Would Act as an Indirect Benefit Cut to Millions of Americans
retire.ly6 hours agofool.com
If I Could Tell Every Dividend Investor 1 Thing About Building Passive Income in 2026, It's This
fool.com6 hours agofool.com
Nvidia Stock Just Did Something for the First Time in 7 Years. Here's What History Says Happens Next.
fool.com6 hours agofool.com
Alphabet vs. Amazon vs. Microsoft: Which Is the Best Cloud Computing Stock to Buy Today?
fool.com7 hours agofool.com
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
fool.com